Analysis
Filter results by
Search HelpKeyword(s)
Year of publication
Author(s)
Survey or statistical program
Results
All (21)
All (21) (0 to 10 of 21 results)
- Articles and reports: 88-003-X200800110580Geography: CanadaDescription:
Data collected through Statistics Canada's life sciences statistics program indicate that Canada has a sizable biotechnology sector in comparison with larger countries in Europe. This program regularly provides assistance to other countries, which view Canada as a world leader in the development of biotechnology statistics. This article notes the future directions and challenges facing the program.
Release date: 2008-05-22 - Articles and reports: 88F0006X2007006Description:
This descriptive working paper provides highlights from the Biotechnology Use and Development Survey 2005. Data on innovative biotechnology firms are presented by region, sectors and firm size. The data include firm revenues, R&D activities, human resources, firm financing, age of firms, country of control and the proportion of publicly traded firms.
Release date: 2007-12-05 - 3. Results of the pilot survey on nanotechnologies ArchivedArticles and reports: 88-003-X200700210323Geography: CanadaDescription:
Although nanotechnology can be thought of as a sector of its own, it is clear that nanotechnology is a cross-sector phenomenon with potentially significant impacts. Nanotechnologies can be found in areas as diverse as biotechnology and health, agriculture, electronics and computer technology, environment and energy, optics, and in materials and manufacturing.
Release date: 2007-10-09 - Articles and reports: 88-003-X200700210324Geography: CanadaDescription:
Statistics Canada is actively involved with the international community in developing statistical information on nanotechnologies. This article summarizes the ongoing work of the OECD's newly-established Working Party on Nanotechnology, with particular emphasis on the role of Statistics Canada.
Release date: 2007-10-09 - Articles and reports: 88F0006X2007005Description:
This working paper provides results from a pilot survey on nanotechnology, which was appended to the Biotechnology Use and Development Survey 2005. The paper presents the conceptual issues and survey challenges relating to measurement of nanotechnology-related activities, as well as preliminary data on nanotechnology firms in Canada.
Release date: 2007-08-31 - Articles and reports: 88-003-X20060029240Geography: CanadaDescription:
This article summarizes the Canadian experience in collecting and accessing information on government expenditure (both federal and provincial) on nanotechnology R&D in Canada. The steps taken to measure activities in the private sector on nanotechnology illustrate the many challenges facing measurement of nanotechnology activities.
Release date: 2006-06-27 - 7. Canadian biotechnology activity, 2003 ArchivedArticles and reports: 88-003-X20050028021Geography: CanadaDescription:
Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.
Release date: 2005-06-20 - Articles and reports: 88F0006X2005009Description:
The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2003 Biotechnology Use and Development Survey. Within the last few years, except for the number of employees with biotechnology-related responsibilities that remained stable, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 375 in 2001 to 490 in 2003 and biotechnology revenues rose from $3.6 billion to $3.8 billion between 2001 and 2003. Also, biotechnology R&D spending increased by 11% between 2001 and 2003 and the amount of capital raised for biotechnology was up 73% during this period.
Release date: 2005-04-27 - Articles and reports: 88-003-X20050017768Geography: CanadaDescription:
This article presents data on nanotechnology firms from two perspectives. The first is the number and distribution of firms engaged in research and development of nanotechnologies. The second perspective examines companies providing services to nanotechnology firms. These data contribute to an emerging understanding of the level of nanotechnology activity in the business sector of the Canadian economy.
Release date: 2005-02-09 - 10. A discussion of the emerging nanotechnology ArchivedArticles and reports: 88-003-X20030026561Geography: CanadaDescription:
Nanotechnology is an emerging technology. Has it reached the point that warrants the development of a comprehensive statistical measurement program? If so, what indicators should be used? Major spending initiatives in nanotechnology investing are currently underway. There is precedence for using developed methods and techniques to address the questions 'who,' 'what,' 'where' and 'why.' Statistics Canada's experience may be invaluable in the development of a nanotechnology statistical program.
Release date: 2003-06-27
Stats in brief (0)
Stats in brief (0) (0 results)
No content available at this time.
Articles and reports (21)
Articles and reports (21) (0 to 10 of 21 results)
- Articles and reports: 88-003-X200800110580Geography: CanadaDescription:
Data collected through Statistics Canada's life sciences statistics program indicate that Canada has a sizable biotechnology sector in comparison with larger countries in Europe. This program regularly provides assistance to other countries, which view Canada as a world leader in the development of biotechnology statistics. This article notes the future directions and challenges facing the program.
Release date: 2008-05-22 - Articles and reports: 88F0006X2007006Description:
This descriptive working paper provides highlights from the Biotechnology Use and Development Survey 2005. Data on innovative biotechnology firms are presented by region, sectors and firm size. The data include firm revenues, R&D activities, human resources, firm financing, age of firms, country of control and the proportion of publicly traded firms.
Release date: 2007-12-05 - 3. Results of the pilot survey on nanotechnologies ArchivedArticles and reports: 88-003-X200700210323Geography: CanadaDescription:
Although nanotechnology can be thought of as a sector of its own, it is clear that nanotechnology is a cross-sector phenomenon with potentially significant impacts. Nanotechnologies can be found in areas as diverse as biotechnology and health, agriculture, electronics and computer technology, environment and energy, optics, and in materials and manufacturing.
Release date: 2007-10-09 - Articles and reports: 88-003-X200700210324Geography: CanadaDescription:
Statistics Canada is actively involved with the international community in developing statistical information on nanotechnologies. This article summarizes the ongoing work of the OECD's newly-established Working Party on Nanotechnology, with particular emphasis on the role of Statistics Canada.
Release date: 2007-10-09 - Articles and reports: 88F0006X2007005Description:
This working paper provides results from a pilot survey on nanotechnology, which was appended to the Biotechnology Use and Development Survey 2005. The paper presents the conceptual issues and survey challenges relating to measurement of nanotechnology-related activities, as well as preliminary data on nanotechnology firms in Canada.
Release date: 2007-08-31 - Articles and reports: 88-003-X20060029240Geography: CanadaDescription:
This article summarizes the Canadian experience in collecting and accessing information on government expenditure (both federal and provincial) on nanotechnology R&D in Canada. The steps taken to measure activities in the private sector on nanotechnology illustrate the many challenges facing measurement of nanotechnology activities.
Release date: 2006-06-27 - 7. Canadian biotechnology activity, 2003 ArchivedArticles and reports: 88-003-X20050028021Geography: CanadaDescription:
Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.
Release date: 2005-06-20 - Articles and reports: 88F0006X2005009Description:
The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2003 Biotechnology Use and Development Survey. Within the last few years, except for the number of employees with biotechnology-related responsibilities that remained stable, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 375 in 2001 to 490 in 2003 and biotechnology revenues rose from $3.6 billion to $3.8 billion between 2001 and 2003. Also, biotechnology R&D spending increased by 11% between 2001 and 2003 and the amount of capital raised for biotechnology was up 73% during this period.
Release date: 2005-04-27 - Articles and reports: 88-003-X20050017768Geography: CanadaDescription:
This article presents data on nanotechnology firms from two perspectives. The first is the number and distribution of firms engaged in research and development of nanotechnologies. The second perspective examines companies providing services to nanotechnology firms. These data contribute to an emerging understanding of the level of nanotechnology activity in the business sector of the Canadian economy.
Release date: 2005-02-09 - 10. A discussion of the emerging nanotechnology ArchivedArticles and reports: 88-003-X20030026561Geography: CanadaDescription:
Nanotechnology is an emerging technology. Has it reached the point that warrants the development of a comprehensive statistical measurement program? If so, what indicators should be used? Major spending initiatives in nanotechnology investing are currently underway. There is precedence for using developed methods and techniques to address the questions 'who,' 'what,' 'where' and 'why.' Statistics Canada's experience may be invaluable in the development of a nanotechnology statistical program.
Release date: 2003-06-27
Journals and periodicals (0)
Journals and periodicals (0) (0 results)
No content available at this time.
- Date modified: